LeapZipBlog: Pramod Parmar

Pramod Parmar's blog

59 blogs

Tattoo Removal Lasers Market Expected to Reach US$ 285.3 Mn by 2026

March 14, 2019 by Pramod Parmar  

The latest market report published by Credence Research, Inc. “Tattoo Removal Lasers Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global tattoo removal lasers market was valued at US$ 159.0 Mn in 2017 and expected to reach US$ 285.3 Mn by 2026, expanding at a CAGR of 6.5% from 2018 to 2026.

Browse the full report Tattoo Removal Lasers Market - Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/tattoo-removal-lasers-market

Market Insights:

Increasing awareness about safe and convenient tattoo removal treatments and rapid uptake of laser treatments in asthetics are the prime factors driving the tattoo removal lasers market. The novel laser removal solutions come with faster recovery time, less side effects and improved safety. These factors have led people to opt for the latest laser removal laser treatments as against the obsolete methods. In the U.S. alone, over 50,000 laser tattoo removals were performed in 2016. Tattoos are becoming a popular part of the latest sociocultural environment. 36% of the American adults have at least one tattoo, with 20% individuals having more than one. However, a significant part of this group has regret on having a tattoo.

Q-switched lasers are the most common laser type used for tattoo removal. Q-switched ruby laser successfully removes black, dark blue and green pigments. However, for multicolor tattoos, combined lasers are often prescribed. The latest picosecond lasers are gaining gradual popularity in the developed markets. These lasers clear tattoo more effectively in lesser time than the conventional counterparts. Picosecond laser also effectively clears pigments such as yellow, orange, red and also removes tattoos with black pigments.

Several new technologies are also being explored for commercialization in the field of tattoo removal. As the awareness of the general public towards tattoo removal is increasing, the demand for lasers for this application is set to augment within the forecast period. However, tattoo removal with lasers come with high costs due to high prices of these equipment, thus making it unaffordable to both patients and therapists. Requirement of multiple sittings also increases the overall treatment cost. Furthermore, multicolor tattoos require combined treatments for efficient tattoo removal, which in turn augments the cost.

Asia Pacific shall be progressing at the fastest growth rate during the forecast period. Getting a tattoo is becoming widely popular and affordable for the general population in Asia Pacific. Therefore, as the uptake of tattoos in the region is growing, there shall be an increase in the number of individuals seeking tattoo removal. Furthermore, cheaper costs of laser tattoo removal in Asia Pacific shall also be assistive in attracting customers to the region. Growing awareness along with improving disposable incomes in the general population is also attracting the uptake of tattoo removal in Asia Pacific.

Key Market Movements:

  • Growing and indiscriminate uptake of tattoos worldwide, and the resultant growing demand for tattoo removal procedures
  • Requirement from certain professions for absence of tattoos at specific sites
  • Increasing awareness in tattoo removals regarding convenient , quick and safer tattoo removal treatments
  • Lesser procedure costs in Asia Pacific attracting patients from other geographies

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared for this task.

Contact Us:
Credence Research Inc.
105 N 1st ST #429
SAN JOSE
CA 95103
United States
Toll Free (US/Canada): +1-800-361-8290

Web: https://www.credenceresearch.com   

Our Blog : http://www.newsnreport.com

Anticoagulants Market Analysis, Size, Regional Outlook, Share, Trend, Growth, Analysis and Forecast Report 2026

March 14, 2019 by Pramod Parmar  

The latest market report published by Credence Research, Inc. “Anticoagulants Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global anticoagulants market was valued at US$ 33,150.7 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 6.6% during the forecast period from 2018 to 2026.

Browse full report at https://www.credenceresearch.com/report/anticoagulants-market

Market Insights 

The global anticoagulants market is projected to grow at a steady rate during the forecast period attributable to launch of drugs with lower side effects and higher efficacy, growing prevalence of cardiovascular diseases globally and higher adoption of novel oral anticoagulants (NOACs) in North America and Europe. Promising pipeline will further drive the market during the forecast period. For instance, Ionis Pharmaceutical is developing a novel antisense drug named IONIS- FXIRx that is designed to reduce the production of coagulation factor XI that plays a key role in proliferation of clots. The drug is in phase II of clinical trials and claims to have positive results when tested in patients undergoing replacement to prevent venous thrombosis. Espero Biopharma phase III candidate, a vitamin K antagonist named Tecarfarin claims of having fewer adverse effects and lesser drug-drug interaction as compared to warfarin. Thus, these promising drug candidates will drive the market in the latter stage of the forecast period. In terms of application, the market is segmented into atrial fibrillation & heart attacks, strokes, deep vein thrombosis (DVT), and pulmonary embolism. In 2017, atrial fibrillation (AF) & heart attacks held the largest share in the anticoagulants market owing to large target population of patients suffering from atrial fibrillation and growing incidence of heart attacks. According to recent study in Britain, it is estimated that 1.4 million British people at a high risk of strokes due to non-valvular atrial fibrillation (NVAF). AF prevalence is higher in North America and Asia Pacific, thereby driving the market due to increased usage of anticoagulants. Deep vein thrombosis is expected to show significant growth rate during the forecast period, due to growing cases and products specifically targeting DVT.

In terms of geography, North America held the largest share of over 48% in the global anticoagulants market. The increasing usage of NOACs in the region is the major driving factor for the growth of the market. Xarelto and Eliquis are the most prescribed drugs in the U.S. followed by warfarin. Structured approval policies by the U.S. Food and Drug Administration (FDA) and efficient reimbursement scenario drive the market in North America. Asia Pacific emerged as the fastest growing region owing to high target population, lucrative opportunities for foreign players to invest in and ever-growing prevalence of cardiovascular diseases. Furthermore, growing number of pharmaceutical players indulging in research & development of anticoagulants and growing health awareness will further drive the market. The key players currently engaged in anticoagulants market include Bayer AG, Janssen Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Pfizer, Inc., Daiichi Sankyo Company Limited, and Portola Pharmaceuticals, Inc. among others.

Key Market Movements:

  • Promising pipeline for anticoagulants in North America and Europe to drive the market during the forecast period
  • Growing research and development by pharmaceutical players further boost market growth
  • Rising prevalence of cardiovascular disease such as atrial fibrillation, DVT and coronary heart diseases

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared for this task.

Contact Us:
Credence Research Inc.
105 N 1st ST #429
SAN JOSE
CA 95103
United States
Toll Free (US/Canada): +1-800-361-8290

Web: https://www.credenceresearch.com   

Our Blog : http://www.newsnreport.com

Global Tympanostomy Products Market Is Set To Grow At A CAGR Of 1.9% By 2026

March 14, 2019 by Pramod Parmar  

The latest market report published by Credence Research, Inc. “Global Tympanostomy Products Market- Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global tympanostomy products market is set to reach from US$ 79.3 Mn in 2017 to US$ 93.4 Mn by 2026 expanding at a CAGR of 1.9% from 2018 to 2026.

Browse the full report Tympanostomy Products Market - Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/tympanostomy-products-market

Market Insights

Otitis media is the infection of the middle ear region which is characterized by high degree of inflammation and purulent secretions in severe cases. Tympanostomy products aid in draining infectious ear fluids and equalizing pressure. It has a high prevalence rate worldwide. The limiting factor associated with this market is the availability of product pipeline of promising topical antibiotics possessing excellent efficacy and safety profile. Eustachian tube balloon dilation devices may pose a threat to tympanostomy products market growth.

Tube inserters are dominating the products segment for tympanostomy products market. Lack of general anesthesia during insertion and removal procedures and availability of novel inserters has resulted in tis popularity among ENT surgeons worldwide. Tympanostomy tubes will register impressive growth in the near future on account of availability of latest antimicrobial coated and bioresorbable tubes for treating middle ear infections.

Fluoroplastic material are reigning the tympanostomy products market. Inherent features such as excellent biocompatibility, smoothness and beveled shape resisting occlusion drive the market growth for fluoroplastic materials. Silicone material are in huge demands on account of its physic-chemical properties such as elasticity, compliant nature and soft nature can be easily manipulated. Lubricity helps in insertion and removal of tympanostomy products with safety and ease.

Recurrent otitis media with effusion is holding the largest application market for tympanostomy products. It has a high prevalence rate in children often resulting due to antibiotic resistance to initial middle ear infection and increasing demand for tympanostomy procedure for treating recurrent otitis media with effusion. Chronic otitis media is widely occurring in adult population due to infection of the tympanic membrane caused due to infection of the upper respiratory tract. Reddening of tympanic membrane and inflammation of the eustachian tube often results in chronic otitis media.

North America is leading the regional segment for tympanostomy products market with 35% share. The primary factors responsible for its market growth are rising prevalence of otitis media and domicile of key players such as Medtronic, Plc., Atos Medical and Olympus Corporation. Europe is the second largest regional market for tympanostomy products and currently holds 25% market share. Affordable reimbursement scenario for tympanostomy products and supportive regulatory environment provided by European Medical Agency (EMA). Asia Pacific is accountable for 15% market share and will be registering fastest growth during the forecast period owing to increasing number of patients suffering with middle ear infection and significant growth in medical tourism.

Major medical device manufacturers producing Tympanostomy products are Atos Medical, Adept Medical, EON Meditech, Koken Co., Ltd., Medtronic, Plc., OtoMedics Advanced Medical Technologies, Olympus Corporation, Preceptis Medical, Summit Medical Group and Teleflex Incorporated.

Key Market Movements:

  • Rising prevalence of otitis media in children throughout the globe
  • Availability of latest design, biocompatible, smooth and highly lubricant fluoroplastic and silicon material tympanostomy devices
  • Affordable reimbursement scenario in developed nations for tympanostomy products

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared for this task.

Contact Us:
Credence Research Inc.
105 N 1st ST #429
SAN JOSE
CA 95103
United States
Toll Free (US/Canada): +1-800-361-8290

Web: https://www.credenceresearch.com   

Our Blog : http://www.newsnreport.com

Handheld Ultrasound Scanners Market Growth Trends, Size, Share, Key Players, Competitive Strategies and Forecasts 2026

March 11, 2019 by Pramod Parmar  

The latest market report published by Credence Research, Inc. “Handheld Ultrasound Scanners Market- Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global handheld ultrasound scanners market was valued at US$ 62.2 Mn in 2017 expanding at a CAGR of 17.0% from 2018 to 2026.

Browse the full report at : https://www.credenceresearch.com/report/handheld-ultrasound-scanners-market

Market Insights

The handheld ultrasound scanners market has flourished during the last decade as number of the major medical devices companies are coming up with portable and handheld ultrasound devices. The uptake of handheld ultrasound units are growing rapidly due to low market entry barriers as regulatory scenario of portable ultrasound is not defined in many regions, advances in consumer electronics have made handheld ultrasound inexpensive to design and manufacture. Portability, easy to use, inexpensive as compared to conventional ultrasound devices are the major advantages of handheld ultrasound scanners. Moreover, handheld ultrasound scanners are equipped with minimum wires, cloud sharing facility, advanced imaging quality and battery life making ultrasound more portable and less infrastructure dependent. Handheld ultrasound scanners are becoming increasingly popular among clinicians across the globe for point-of-care diagnosis. These devices are used for imaging internal organs, cardiovascular, and gynecology imaging.

In terms of technology, 2D ultrasound scanners held the largest share in the global handheld scanners market owing to growing demand for efficient and better imaging quality, rapid introduction of handheld 2D ultrasound products my majority of the manufacturers and higher demand for these devices by physicians. Handheld 3D ultrasound scanners are comparatively less inexpensive as compared to conventional cart based ultrasound scanners and provide same image quality. This is the prime factor for the inclination of healthcare practitioners towards handheld 3D ultrasound scanners. Thus, 3D handheld ultrasound scanners are expected to grow at steady rate during the forecast period due to its high application in point-of-care diagnostics.

In terms of geography, North America held the largest share for handheld ultrasound scanners and expected to grow at a steady rate during the forecast period. Higher adoption of novel technology and approvals of number of handheld ultrasound scanners in the region will further drive the market during the forecast period. Growing number ambulatory care centers in the U.S. will generate demand for portable ultrasound devices. Europe exhibits high potential in global handheld ultrasound scanners market. Key factors assisting the market growth in this region include growing clinical applications of high intensity focused ultrasound, commercialization of number of portable ultrasound and growing minimally invasive practices. Asia Pacific is projected to grow at rapid rate in the global handheld ultrasound scanners market owing to growth of standalone clinics and diagnostics centers in the region. Lower prices, easy availability and less skilled required to operate these products will trigger market growth in price sensitive regions like Asia Pacific. The prominent players actively participating in the handheld ultrasound scanners market include GE Healthcare, Samsung Group, Siemens Healthineers, Philips Healthcare, Clarius Mobile Health, Fujifilm SonoSite, Inc., Healcerion Co., Ltd., Sonoscanner SARL, Meditech Equipment among others.

Key Market Movements:

  • Growing inclination towards handheld ultrasound scanners for point-of-care diagnostics
  • Lower capital investment required for handheld ultrasound scanners compared to conventional ultrasound devices
  • Growing number of diagnostics centers and ambulatory care centers globally to drive the market for handheld ultrasound scanners
  • Portability and cloud connectivity features of handheld ultrasound scanners will further drive the market

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared for this task.

Contact Us:
Credence Research Inc.
105 N 1st ST #429
SAN JOSE
CA 95103
United States
Toll Free (US/Canada): +1-800-361-8290

Web: https://www.credenceresearch.com   

Our Blog : http://www.newsnreport.com

Global Medical Marijuana Market Is Expected To Reach US$ 57,582.5 Mn By 2026

March 11, 2019 by Pramod Parmar  

The latest market report published by Credence Research, Inc. “Global Medical Marijuana Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global medical marijuana market was valued at US$ 13,908.7 Mn in 2017, and is expected to reach US$ 57,582.5 Mn by 2026, expanding at a CAGR of 17.1% from 2018 to 2026.

Browse the full report Medical Marijuana Market - Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at  https://www.credenceresearch.com/report/medical-marijuana-market

Market Insights

Cannabionoids are natural extracts derived from Cannabis sativa, Cannabis indica and Cannabis ruderalis. For centuries marijuana has been used extensively for recreational, medical and ritualistic purposes. It comprises of psychoactive drug component tetrahydrocannabinol which causes the stimulation of the cannabinoid receptor CB1 and CB2 respectively. The activation of these receptors results in pain relieving activity in patients suffering with chronic pain due to AIDS, cancer, neuropathic pain etc., In the last decade marijuana has been a keen research subject for researchers and academicians throughout the globe to understand its therapeutic benefits in treating anorexia and nausea. Positive steps have been taken by healthcare and law enforcing agencies to legalize the production and sale of marijuana for medicinal purpose. Tremendous focus is laid in drafting guidelines for the judicious use of marijuana in healthcare centers. Nowadays marijuana is available as weed infused gums, tampons, cannabinoid infused tea, bath salts, cannabinoid infused coffee and topical balms to get relief from pain.

Cancer is currently dominating the applications segment on account of large patient pool suffering with chronic pain and nausea during chemotherapy. Marijuana have been found beneficial in treating patients with neurological disorders such as epilepsy, seizures etc., due to its sedative effects. Chronic pain will gain momentum due to increasing number of patients suffering with musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis and other autoimmune diseases such as psoriasis and multiple sclerosis.

In the present scenario hospital pharmacies are dominating the point of sale segment on account of key parameters such as availability of medical marijuana at low cost and strict monitoring of cancer patients availing marijuana for treating chronic pain. Dispensaries will register good growth during the forecast period due to increasing number of patients suffering with anorexia and nausea and government permit to dispense marijuana on regular basis to patients suffering with chronic pain.

North America is the global leader in medical marijuana market owing to the rising prevalence of cancer and proactive policies implemented by USFDA legalizing the production and sale of marijuana for treating chronic pain. Germany has drafted regulatory guidelines for the use of marijuana for medicinal purpose which also serves as a gold standard for other European Union countries. Rest of the World serves as a lucrative market as it is the largest producer of marijuana in the world and regulatory agencies are taking proactive steps to legalize the production and sale of marijuana for therapeutic use.

The key players actively engaged in the production and sale of marijuana are AbbVie, Inc., CannaGrow Holdings, Inc., Canopy Growth Corporation, Inc., GW Pharmaceuticals, Plc. Insys Therapeutics, Inc., Novartis AG, Lexaria Corporation, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and United Cannabis Corporation.

Key Market Movements:

  • Rising prevalence of cancer and patients suffering with chronic pain
  • Increased research funding for determining the therapeutic efficacy of marijuana for treating anorexia and nausea
  • Supportive regulatory environment for the production and sale of marijuana for medicinal purposes

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared for this task.

Contact Us:
Credence Research Inc.
105 N 1st ST #429
SAN JOSE
CA 95103
United States
Toll Free (US/Canada): +1-800-361-8290

Web: https://www.credenceresearch.com   

Our Blog : http://www.newsnreport.com

Global Medical Marijuana Market Is Expected To Reach US$ 57,582.5 Mn By 2026

March 11, 2019 by Pramod Parmar  

The latest market report published by Credence Research, Inc. “Global Medical Marijuana Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global medical marijuana market was valued at US$ 13,908.7 Mn in 2017, and is expected to reach US$ 57,582.5 Mn by 2026, expanding at a CAGR of 17.1% from 2018 to 2026.

Browse the full report Medical Marijuana Market - Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at  https://www.credenceresearch.com/report/medical-marijuana-market

Market Insights

Cannabionoids are natural extracts derived from Cannabis sativa, Cannabis indica and Cannabis ruderalis. For centuries marijuana has been used extensively for recreational, medical and ritualistic purposes. It comprises of psychoactive drug component tetrahydrocannabinol which causes the stimulation of the cannabinoid receptor CB1 and CB2 respectively. The activation of these receptors results in pain relieving activity in patients suffering with chronic pain due to AIDS, cancer, neuropathic pain etc., In the last decade marijuana has been a keen research subject for researchers and academicians throughout the globe to understand its therapeutic benefits in treating anorexia and nausea. Positive steps have been taken by healthcare and law enforcing agencies to legalize the production and sale of marijuana for medicinal purpose. Tremendous focus is laid in drafting guidelines for the judicious use of marijuana in healthcare centers. Nowadays marijuana is available as weed infused gums, tampons, cannabinoid infused tea, bath salts, cannabinoid infused coffee and topical balms to get relief from pain.

Cancer is currently dominating the applications segment on account of large patient pool suffering with chronic pain and nausea during chemotherapy. Marijuana have been found beneficial in treating patients with neurological disorders such as epilepsy, seizures etc., due to its sedative effects. Chronic pain will gain momentum due to increasing number of patients suffering with musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis and other autoimmune diseases such as psoriasis and multiple sclerosis.

In the present scenario hospital pharmacies are dominating the point of sale segment on account of key parameters such as availability of medical marijuana at low cost and strict monitoring of cancer patients availing marijuana for treating chronic pain. Dispensaries will register good growth during the forecast period due to increasing number of patients suffering with anorexia and nausea and government permit to dispense marijuana on regular basis to patients suffering with chronic pain.

North America is the global leader in medical marijuana market owing to the rising prevalence of cancer and proactive policies implemented by USFDA legalizing the production and sale of marijuana for treating chronic pain. Germany has drafted regulatory guidelines for the use of marijuana for medicinal purpose which also serves as a gold standard for other European Union countries. Rest of the World serves as a lucrative market as it is the largest producer of marijuana in the world and regulatory agencies are taking proactive steps to legalize the production and sale of marijuana for therapeutic use.

The key players actively engaged in the production and sale of marijuana are AbbVie, Inc., CannaGrow Holdings, Inc., Canopy Growth Corporation, Inc., GW Pharmaceuticals, Plc. Insys Therapeutics, Inc., Novartis AG, Lexaria Corporation, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and United Cannabis Corporation.

Key Market Movements:

  • Rising prevalence of cancer and patients suffering with chronic pain
  • Increased research funding for determining the therapeutic efficacy of marijuana for treating anorexia and nausea
  • Supportive regulatory environment for the production and sale of marijuana for medicinal purposes

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared for this task.

Contact Us:
Credence Research Inc.
105 N 1st ST #429
SAN JOSE
CA 95103
United States
Toll Free (US/Canada): +1-800-361-8290

Web: https://www.credenceresearch.com   

Our Blog : http://www.newsnreport.com

Deep Brain Stimulation Devices Market Expected To Reach US$ 9,548.0 Mn By 2026

March 11, 2019 by Pramod Parmar  

The latest market report published by Credence Research, Inc. “Deep Brain Stimulation Devices Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global deep brain stimulation devices market was valued at US$ 699.6 Mn in 2017 and expected to reach US$ 1,889.4 Mn by 2026, expanding at a CAGR of 11.6% from 2018 to 2026.

Browse the full report Deep Brain Stimulation Devices Market - Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at  https://www.credenceresearch.com/report/deep-brain-stimulation-devices-market

Market Insights

Since the first application of deep brain stimulation (DBS) in the 1990s, the indications for the potential use of deep brain stimulation devices have been expanding. At present, over 1.5 million individuals have undergone DBS treatment for several approved and off label indications. Reversibility and titratability are the key features of deep brain stimulation devices augmenting their appeal in the field of clinical neurology. Despite their perceived advantages, the USFDA has been cautious in the approval and widespread adoption of deep brain stimulation treatments. Parkinson’s disease, epilepsy and tremors have been approved by the FDA with dystonia and obsessive compulsive disorders being granted exemption under humanitarian grounds. Conversely, the European commission is being more liberal in granting direct approval for these conditions. DBS has been applied for several conditions with proved benefits. However, due to scarcity of the number of procedures, robust evidence owing to difficulty in performing double blind randomized trials for such conditions is lacking.

As the global burden of neurological diseases is increasing, the healthcare infrastructure worldwide is augmenting its efforts towards introducing and incorporating new treatment methods and modalities that shall assist in mitigating the ever-growing toll of diseases. High morbidity has therefore created clinical urgency for long-term treatment options such as deep brain stimulation. Deep brain stimulation devices have proven evidence to have an important role in offering potential treatment to conditions such as epilepsy, tremors, and Parkinson’s disease, and are being further explored for their viability in other neurological areas.

Advancements in deep brain stimulation device technologies are shaping the growth of this market. Some of such advancements include customized programming, robot-assisted implantations, integrated pulse generators, and so on. Such progresses have allowed better treatment outcomes and safety profile to deep brain stimulation devices, particularly in treatment of movement disorders. At present, among the several approved applications of deep brain stimulation devices, Parkinson’s disease dominates the global market both in terms of revenue and volume. Parkinson’s disease is a common neurological disease with less treatment alternatives, and the available treatments are often administered for life. Long-term costs of Parkinson’s medications have led to increased adoption of deep brain stimulation devices, therefore gaining a greater market share. Additionally, the recently approved epilepsy application is expected to undergo the fastest growth during the forecast period. Lower therapeutic response to medication and lower outcomes from surgeries will urge chronic patients to adopt deep brain stimulation as a potential treatment.

The global deep brain stimulation devices market is highly competitive and consolidated. The market is characterized by the presence of limited number of players. The major companies operating in this market are engaged in developing next generation devices that shall deliver better treatment outcomes, with expanded application areas with legal sanction. The companies are also actively engaged expanding their geographical reach, and improving distribution channels with partnerships and distribution agreements.

Key Market Movements:

  • Growing prevalence of neurodegenerative diseases such as Parkinson’s disease and other movement disorders
  • Lack of availability of viable and more efficacious treatment options for such diseases
  • Growing preference of neurostimulation devices for treatment of neurological conditions
  • Intensive marketing strategies in North America and Europe
  • Intensive research and development activities promoting the efficacy of DBS devices

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared for this task.

Contact Us:
Credence Research Inc.
105 N 1st ST #429
SAN JOSE
CA 95103
United States
Toll Free (US/Canada): +1-800-361-8290

Web: https://www.credenceresearch.com   

Our Blog : http://www.newsnreport.com

Airport Baggage Handling Systems Market Share, Size, Growth, Trends, Industry Analysis and Forecast 2026

March 11, 2019 by Pramod Parmar  

According to a new market research report published by Credence Research “Airport Baggage Handling Systems Market (Technology – Barcode System and Radio-frequency Identification (RFID); Solution – Sorting, Conveying, Tracking & Tracing and Diverting) – Growth, Future Prospects and Competitive Analysis, 2018 – 2026”, the global airport baggage handling systems market was valued at US$ 8.14 Bn in 2017 and will be growing at a CAGR of 8.2% during the forecast period from 2018 to 2026.

Browse the full report at  https://www.credenceresearch.com/report/airport-baggage-handling-systems-market

Market Insights

The airport baggage handling systems market was valued at US$ 8.14 Bn in 2017 and expected to grow at a compounded annual growth rate (CAGR) of 8.2% during the forecast period from 2018 to 2026. Airports across the world in an urge to improve the operational efficiency of airports are focusing on deploying efficient baggage handling systems. Moreover, deploying these systems also helps to improve the experience of passengers. Reduction in aircraft turnaround time coupled with better convenience for passengers are the two most important benefits offered by these systems. The demand for airport baggage handling systems has been positively influenced by airport modernization programs implemented across various countries. The number of air passengers has witnessed a significant growth in recent years especially in regions such as Asia Pacific and Middle East & Africa. This in turn has resulted in establishment of new airports as well as expansion of the existing ones. These factors in combination are expected to compliment the baggage handling systems market growth.

Asia Pacific expected to remain as the most important market for investment in coming years. Governments in countries such as China and India have been largely instrumental in funding activities pertaining to airport modernization. In recent years, the number of passengers travelling through airways in the Asia Pacific region has increased significantly. This trend is likely to continue in the coming years. With increasing disposable income of people, the demand for air travel in countries/regions including China, India and South Asia has increased significantly in recent years. As per reports by IATA, China expected to displace the United States as the world’s largest aviation market around the year 2022. Similarly, India expected to surpass U.K. in 2025 and occupy the 4th position globally. The growth of the aviation industry in India can be understood from data released by aviation regulator, Directorate General of Civil Aviation (DGCA), which suggests India’s domestic air traffic nearly doubled to 117.18 million passengers in 2017 as compared to 59.87 million in 2011. Moreover, rising middle class, lower air ticket prices and improving regional connectivity are other prominent factors complimenting aviation industry growth in Asia Pacific. These factors in combination expected to positively influence the airport baggage handling systems market growth in the coming years.

Some of the major players operating in the airport baggage handling systems market include Vanderlande Industries, Siemens AG, Pteris Global Limited, Daifuku Company Ltd., Beumer Group, BCS Group, Grenzebach Maschinenbau GmbH, G&S Airport Conveyor, Scarabee Systems & Technology B.V., Logplan Llc, Alstef Automation S.A., SITA and Fives Group among others.

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared for this task.

Contact Us:
Credence Research Inc.
105 N 1st ST #429
SAN JOSE
CA 95103
United States
Toll Free (US/Canada): +1-800-361-8290

Web: https://www.credenceresearch.com   

Our Blog : http://www.newsnreport.com

Autonomous Construction Equipment Market Size, Share, Trends, Growth, Regional Outlook and Forecast 2026

March 11, 2019 by Pramod Parmar  

According to a new market research report published by Credence Research “Autonomous Construction Equipment Market (by Equipment: Earth Moving Equipment, Construction Vehicles, Material Handling Equipment, Concrete & Road Construction Equipment; by Autonomy: Partial Autonomous and Fully Autonomous) - Growth, Future Prospects, and Competitive Landscape, 2018-2026”, the autonomous construction equipment are all set to change the dynamics of construction industry and projected to grow with a CAGR of 28.7% during the forecast period from 2018 to 2026.

The complete report is available at  https://www.credenceresearch.com/report/autonomous-construction-equipment-market

Market Insights

Construction industry is considered as one of the least efficient industries; although, the industry has been registering market value of more than US$ 10 Tn consistently in past few years. Not only inefficient, but construction industry is also considered as one of the most perilous industry to work. Much of the blame for aforementioned negative goes to the lack of research & development besides cyclic nature and stringent government regulations. However, the industry is on the cusp of radical changes and welcoming new technologies such as autonomous construction equipment with arms open. Autonomous construction equipment getting ready to make the industry safer and more efficient by combining merits of robotics and advanced artificial intelligence supported by progressive GPS & navigation systems. Global mining enterprise Rio Tinto was among the first to introduce autonomous dump-trucks at Pilbara iron-ore mines in Western Australia. The Company is using 73 autonomous dump-trucks from 2015 and the instances supports the fact of autonomous construction equipment projected to live up to their promise for efficiency, productivity and safe operation.

Recognizing the opportunity, several construction equipment giants announced their participation in developing and commercializing autonomous construction equipment. In 2017, Komatsu entered into a strategic agreement with Nvidia to develop GPU chips to visualize and analyze constructions sites. This was an integral part of Company’s smart construction initiative for promotion of autonomous construction equipment. In other instances, global leaders including Caterpillar, Hitachi Construction Machinery and Volvo Construction Equipment announced their autonomous projects and started testing their equipment. This has certainly created a positive outlook towards autonomous construction equipment and potentially huge market in the making.

Competitive Insights:

At first instance, autonomous construction equipment market may seem uncertain for new ventures and start-ups. However, Built Robotics, a start-up created by ex-Googler, developed a self-driving bulldozer and raised a sum of US$ 15 Mn for commercializing their product. Several other new ventures including Cyngn, Cooper Gray Robotics, and Fastbrick Robotics among others are making their presence felt in the market. These companies are raising subsequent amount of money and can prove disruptive to market giants. Few of the notable players mapped in the market study includes Komatsu Ltd., Caterpillar Inc., Hitachi Construction Machinery Co., Ltd., Volvo Construction Equipment, Built Robotics, Inc., Cyngn, Royal Truck & Equipment, Case Construction Equipment, and Deere and Company among others.

Key Analysis Covered:

  • Forthcoming trends in autonomous construction equipment market and growth prospects for leading construction equipment manufacturers
  • Advanced technology playing vital part in design and development of autonomous construction equipment and its impact on future generation of construction equipment
  • Most appropriate market estimation for different autonomous construction products and their credible growth throughout the forecast period
  • Largest and fastest growing segments in terms of equipment and automation
  • Most prominent markets to watch out for the autonomous construction equipment market in coming years

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared for this task.

Contact Us:
Credence Research Inc.
105 N 1st ST #429
SAN JOSE
CA 95103
United States
Toll Free (US/Canada): +1-800-361-8290

Web: https://www.credenceresearch.com   

Our Blog : http://www.newsnreport.com

Liquid Smoke Market Is Expected To Expand At A Cagr Of 6.3% From 2017 To 2025

March 11, 2019 by Pramod Parmar  

According to a new market report published by Credence Research “Global Liquid Smoke Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025,” the liquid smokes market is expected to expand at a CAGR of 6.3% from 2017 to 2025.

Browse the full Liquid Smoke Market by Product Type (Hickory, Mesquite, Apple wood and Others) and by Application (Seafood & Meat, Sauces, Dairy, Pet foods & Treats and Others) - Market Growth, Future Prospects and Competitive Analysis, 2017 – 2025 Link;- https://www.credenceresearch.com/report/liquid-smoke-market

Market Insights

Liquid smoke is modern type of food flavoring widely embraced among meat products, poultry, fish, and non-meat foods such as cheese, tofu, etc. Liquid smoke possesses multiple functional properties such as it is used as an antimicrobial in food preservation, which increases its prominence among food industry. Additionally, Food and Development authority (FDA) has approved its status as Generally Regarded as Safe (GRAS) food additive. GRAS food additive imparts flavor and color to food products depending upon its composition of phenol and carbonyl compounds.

The liquid smoke market is witnessing significant growth owing to growing scope and interest of manufacturers in natural antimicrobials to prevent ready-to-eat poultry and meat products from spoilage. The anti-listerial properties of liquid smoke used to retard the formation of lipid oxidation in many meat products is poised to stimulate the market. Moreover, liquid smoke is being used as a formulation ingredient during the mixing of batter so as to eliminate growth of listeria in the initial phase and impart smoky flavor to product.  Other factors such as lower cost involved in utilizing liquid smoke for imparting flavor in comparison to traditional methods, along with lesser environmental impact are also supplementing the market size.

Competitive Insights

Key liquid smoke manufacturers are adopting business expansion strategy by luring distributors with increasing gains to strengthen their partnership across the value chain. Furthermore, ongoing R&D over the various methods of application of liquid smoke in food products such as dripping, surface addition and others has further motivated players to invest heavily on this product. Few key players profiled in the value chain include Red Arrow International LLC, Frutarom Savory Solutions Gmbh, Baumer Food Inc., Ruitenberg Ingredients BV, Kerry Group Plc, MSK Ingredients Ltd., Azelis SA and other notable players.

Key Trends

  • Development of Unique Flavors by Major Manufacturers for Product Differentiation
  • Growing Pet Ownership in Developed and Developing Countries
  • Demand for Ready to Eat Products in Asia Pacific offers Huge Market Scope

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared for this task.

Contact Us:
Credence Research Inc.
105 N 1st ST #429
SAN JOSE
CA 95103
United States
Toll Free (US/Canada): +1-800-361-8290

Web: https://www.credenceresearch.com   

Our Blog : http://www.newsnreport.com